Opportunity Information: Apply for PAR 25 220
The National Institutes of Health (NIH) is soliciting applications under the funding opportunity titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)" (Funding Opportunity Number: PAR-25-220). This is a discretionary grant opportunity using the R21 mechanism, which is typically meant to support early-stage, exploratory, or high-impact projects that can move a field forward without requiring a large, long-term infrastructure commitment at the outset. As indicated by "Clinical Trial Not Allowed," the work supported under this announcement cannot include prospective clinical trials; instead, it is centered on analyses of existing (extant) datasets and on building data resources that the broader research community can use.
The main goal of the NOFO is to deepen scientific understanding of how "late talking" children develop over time, and why outcomes vary across individuals. Late talking generally refers to children who show delays in early expressive language (for example, slower growth in spoken vocabulary or later emergence of word combinations) without necessarily having other obvious developmental conditions at the time the delay is first noted. A key issue in this area is that some late talkers catch up and go on to have typical language and academic outcomes, while others continue to experience persistent language difficulties and may show downstream impacts in reading, learning, attention, or social communication. This program is aimed at using existing data to map those developmental trajectories more clearly, identify early predictors of later outcomes, and probe potential mechanisms and pathways that could explain why different children follow different routes.
A defining feature of the opportunity is its emphasis on leveraging extant data rather than collecting entirely new samples from scratch. Applicants are expected to make strong use of already-collected datasets such as longitudinal cohorts, archived language samples, developmental and educational records, prior intervention study datasets (as long as the proposed work is not a new clinical trial), neurodevelopmental or behavioral datasets, or other repositories that include relevant measures of language development and related domains. The intent is to capitalize on the depth and scale of existing information to answer questions that would be time-consuming or costly to address through de novo data collection, especially questions that require long follow-up windows to observe later school-age or adolescent outcomes.
In addition to analysis, the NOFO explicitly supports the creation of open and shared data resources. That means projects are encouraged not only to produce findings, but also to generate curated, well-documented datasets or harmonized variables that can be reused by other investigators. Examples of what this can look like include pooling and harmonizing measures across multiple studies so results can be compared more directly, creating standardized metadata and codebooks to make language measures interpretable across datasets, developing shared analytic pipelines, or producing cleaned and de-identified datasets with clear documentation that can be deposited into appropriate repositories. The overall push is toward transparency, reuse, and accelerating discovery by reducing the friction that often keeps valuable developmental datasets siloed.
Scientifically, NIH is looking for work that can reveal patterns and predictors of outcomes in late talking children and illuminate potential underlying mechanisms, risk factors, and sequelae. "Patterns and predictors" can include early child factors (such as receptive language, phonological skills, gesture use, processing speed, or broader cognitive measures), family and environmental factors (such as socioeconomic context, caregiver input, bilingual language exposure, access to early supports, or family history), and measurement-based markers derived from extant data (for example, trajectories derived from repeated language assessments or features extracted from recorded speech and language samples). "Underlying mechanisms" points to research that can move beyond description into plausible explanatory pathways, such as how auditory processing, attention, motor planning, social communication, or neurodevelopmental differences might shape language growth. "Risk factors" refers to characteristics that increase the likelihood of persistent difficulties, while "sequelae" highlights the downstream consequences that can follow early language delay, potentially including later literacy challenges, academic difficulties, social-emotional effects, or co-occurring developmental concerns.
This opportunity is open to a wide range of applicant organizations, reflecting NIH's interest in broad participation and the fact that relevant datasets and expertise can exist in many sectors. Eligible applicants include state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; non-federally recognized tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in those categories); for-profit organizations other than small businesses; and small businesses. The NOFO also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. (foreign) entities. This broad eligibility is especially relevant for data-centric work, since large cohort studies, clinical archives, and educational datasets may be held by universities, health systems, community organizations, government agencies, or international partners.
Key administrative details provided in the source information include an original closing date of 2025-10-02 and a creation date for the opportunity record of 2024-11-20. The opportunity is categorized under health and social services-related activity areas, and it is associated with CFDA numbers 93.173, 93.242, 93.350, and 93.865, which correspond to NIH-related assistance listings. Some typical grant details such as an award ceiling and expected number of awards are not specified in the provided excerpt, so applicants would need to consult the full announcement and NIH guidance for budget expectations and any institute- or program-specific constraints tied to the R21 mechanism.
Taken together, PAR-25-220 is essentially a targeted call for innovative, data-driven projects that use existing datasets to clarify how late talking unfolds across childhood, what early features best predict later outcomes, and what mechanisms may link early language delays to later functioning. Just as importantly, it aims to leave the field with stronger shared data resources so that findings can be replicated, compared across studies, and extended more quickly by other researchers.Apply for PAR 25 220
- The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173, 93.242, 93.350, 93.865.
- This funding opportunity was created on 2024-11-20.
- Applicants must submit their applications by 2025-10-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)" and the Funding Opportunity Number is PAR-25-220.
Which federal agency is offering this funding opportunity?
The funding opportunity is offered by the National Institutes of Health (NIH).
What type of grant mechanism is being used?
This is a discretionary grant opportunity using the NIH R21 mechanism. The R21 is typically used to support early-stage, exploratory, or potentially high-impact projects that can move a field forward without requiring a large, long-term infrastructure commitment at the outset.
Are clinical trials allowed under this opportunity?
No. The announcement specifies "Clinical Trial Not Allowed," meaning supported projects cannot include prospective clinical trials. The focus is on analyses of existing (extant) datasets and on building data resources.
What is the main purpose of PAR-25-220?
The main goal is to deepen scientific understanding of how "late talking" children develop over time and why outcomes vary across individuals, using existing data to map developmental trajectories, identify early predictors of later outcomes, and examine potential mechanisms and pathways.
What does "late talking" mean in the context of this opportunity?
Late talking generally refers to children who show delays in early expressive language (for example, slower growth in spoken vocabulary or later emergence of word combinations) without necessarily having other obvious developmental conditions at the time the delay is first noted.
Why is NIH focusing on late talking children?
A key issue is variability in outcomes: some late talkers catch up and have typical language and academic outcomes, while others experience persistent language difficulties and may have downstream impacts in areas such as reading, learning, attention, or social communication. NIH is seeking research that clarifies these trajectories and what predicts them.
Does this program fund new data collection?
The defining emphasis is on leveraging extant data rather than collecting entirely new samples from scratch. Projects are expected to make strong use of already-collected datasets. The provided information does not describe support for building new cohorts as the central activity; instead, it prioritizes analyses of existing datasets and creation of shareable data resources derived from them.
What kinds of existing datasets are appropriate for this opportunity?
Examples listed include longitudinal cohorts, archived language samples, developmental and educational records, prior intervention study datasets (as long as the proposed work is not a new clinical trial), neurodevelopmental or behavioral datasets, and other repositories that include relevant measures of language development and related domains.
Can data from prior intervention studies be used?
Yes. Prior intervention study datasets can be leveraged, as long as the proposed project does not constitute a new clinical trial.
What kinds of research questions is NIH looking to support?
NIH is looking for work that reveals patterns and predictors of outcomes in late talking children and illuminates potential underlying mechanisms, risk factors, and sequelae (downstream consequences) of early language delay.
What does "patterns and predictors" refer to in this NOFO?
"Patterns and predictors" include early child factors (such as receptive language, phonological skills, gesture use, processing speed, or broader cognitive measures), family and environmental factors (such as socioeconomic context, caregiver input, bilingual language exposure, access to early supports, or family history), and measurement-based markers derived from extant data (such as trajectories from repeated assessments or features extracted from recorded speech and language samples).
What does NIH mean by "underlying mechanisms" in this context?
"Underlying mechanisms" refers to research that goes beyond description into plausible explanatory pathways for why children follow different language-growth routes, including possibilities such as auditory processing, attention, motor planning, social communication, or neurodevelopmental differences shaping language development.
What are "risk factors" and "sequelae" as described in the opportunity?
"Risk factors" are characteristics that increase the likelihood of persistent language difficulties. "Sequelae" are downstream consequences that may follow early language delay, potentially including later literacy challenges, academic difficulties, social-emotional effects, or co-occurring developmental concerns.
Does this opportunity support creating shared or open data resources?
Yes. In addition to analysis, the NOFO explicitly supports creation of open and shared data resources. Projects are encouraged to produce curated, well-documented datasets or harmonized variables that other investigators can reuse.
What are examples of "open and shared data resources" that a project might produce?
Examples provided include pooling and harmonizing measures across multiple studies, creating standardized metadata and codebooks to make language measures interpretable across datasets, developing shared analytic pipelines, and producing cleaned and de-identified datasets with clear documentation for deposit into appropriate repositories.
Why does the NOFO emphasize harmonization and documentation?
The stated intent is to promote transparency and reuse and to accelerate discovery by reducing the friction that keeps valuable developmental datasets siloed, enabling findings to be replicated, compared across studies, and extended more quickly.
Who is eligible to apply for this NIH opportunity?
The opportunity is open to a wide range of applicants, including state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; non-federally recognized tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in those categories); for-profit organizations other than small businesses; and small businesses.
Are certain institution types explicitly highlighted as eligible?
Yes. The NOFO highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. (foreign) entities.
Can non-U.S. (foreign) organizations apply?
Yes. Non-U.S. (foreign) entities are included among the eligible applicants listed in the provided information.
What is the application due date listed in the provided information?
The provided information lists an original closing date of 2025-10-02.
When was the opportunity record created?
The opportunity record creation date is listed as 2024-11-20.
What activity areas is this opportunity associated with?
It is categorized under health and social services-related activity areas.
Which CFDA (assistance listing) numbers are associated with this opportunity?
The opportunity is associated with CFDA numbers 93.173, 93.242, 93.350, and 93.865.
Does the provided information specify an award ceiling or expected number of awards?
No. The excerpt notes that typical grant details such as an award ceiling and expected number of awards are not specified in the provided information, and that applicants would need to consult the full announcement and NIH guidance for budget expectations and any institute- or program-specific constraints tied to the R21 mechanism.
What is the overall takeaway of this funding opportunity?
PAR-25-220 is a targeted call for innovative, data-driven projects that use existing datasets to clarify how late talking unfolds across childhood, identify early predictors of later outcomes, explore mechanisms linking early delays to later functioning, and produce stronger shared data resources to support replication, cross-study comparison, and faster progress in the field.
Browse more opportunities from the same category: Health, Income Security and Social Services
Next opportunity: OVW Fiscal Year 2025 Justice for Families Program
Previous opportunity: Strengthening economic analysis and capacity in support of program management for HIV, TB, and related health threats in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 220
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 220) also looked into and applied for these:
| Funding Opportunity |
|---|
| Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) Apply for PAR 25 217 Funding Number: PAR 25 217 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed) Apply for PAR 25 214 Funding Number: PAR 25 214 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) Apply for PAR 25 265 Funding Number: PAR 25 265 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) Apply for PAR 25 266 Funding Number: PAR 25 266 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional) Apply for RFA HD 26 005 Funding Number: RFA HD 26 005 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) Apply for RFA EY 25 001 Funding Number: RFA EY 25 001 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 296 Funding Number: PAR 25 296 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $650,000 |
| Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) Apply for PAR 25 311 Funding Number: PAR 25 311 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $6,250,000 |
| Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) Apply for PAR 25 362 Funding Number: PAR 25 362 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $400,000 |
| Limited Competition: Advancing the Science of Complementary and Integrative Health Approaches to Improve Maternal Health Outcomes (R01 Clinical Trial Required) Apply for RFA AT 25 002 Funding Number: RFA AT 25 002 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $350,000 |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) Apply for RFA AT 25 003 Funding Number: RFA AT 25 003 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $375,000 |
| Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional) Apply for RFA HD 26 001 Funding Number: RFA HD 26 001 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) Apply for PAR 25 450 Funding Number: PAR 25 450 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 220", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
